发明名称 |
Use of c-Met protein for predicting the efficacy of anti-hepatocyte growth factor (HGF) antibodies in esophageal and gastric cancer patients |
摘要 |
The present invention relates to use of the human Met receptor (also known as "c-Met") for predicting the efficacy of inhibitors of the HGF-Met pathway, and in particular, anti-HGF antibodies, in the treatment of esophageal and gastric cancer patients. The present invention also relates to methods and kits for predicting the usefulness of anti-HGF antibodies in the treatment of esophageal and gastric cancer. |
申请公布号 |
AU2012304362(A1) |
申请公布日期 |
2014.03.06 |
申请号 |
AU20120304362 |
申请日期 |
2012.09.07 |
申请人 |
AMGEN INC. |
发明人 |
ANDERSON, ABRAHAM;OLINER, KELLY;TANG, RUI;LOH, ELWYN;DUBEY, SARITA |
分类号 |
A61K39/395;G01N33/574;G01N33/68 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|